Are you Dr. Lederman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 4 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
166 E 96th St
Apt 17a
New York, NY 10128Phone+1 212-644-2610Fax+1 212-923-5700- Is this information wrong?
Summary
- Dr. Seth Lederman, MD is a rheumatologist in New York, New York. He is currently licensed to practice medicine in New York.
Education & Training
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
Certifications & Licensure
- NY State Medical License 1985 - 2026
Publications & Presentations
PubMed
- 3 citationsPredictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.Sheila A.M. Rauch, H. Myra Kim, Seth Lederman, Gregory M. Sullivan, Ron Acierno, Peter W. Tuerk, Naomi M. Simon, Margaret R. Venners, Sonya B. Norman, Carolyn B. Allar...> ;The Journal of Clinical Psychiatry. 2021 Jun 15
- 5 citationsRandomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response.Gregory M. Sullivan, R. Michael Gendreau, Judith Gendreau, Perry Scott Peters, Ashild Peters, Jean Engels, Bruce L. Daugherty, Benjamin Vaughn, Frank W. Weathers, Seth...> ;Psychiatry Research. 2021 Apr 30
- 123 citationsConstruction of an infectious horsepox virus vaccine from chemically synthesized DNA fragmentsRyan S. Noyce, Seth Lederman, David H. Evans> ;Plos One. 2018 Jan 19
- Join now to see all
Press Mentions
- Tonix Pharmaceuticals Announces the Isolation and Characterization of the (S)-Isomer of Tianeptine, TNX-4300 (Estianeptine), Now Under Development for Psychiatric and Neurodegenerative DiseasesMay 23rd, 2023
- A New Depression Drug Being Developed by Tonix May Side-Step Treatment-Limiting Effects of Nearly All Current Antidepressants in the USApril 27th, 2023
- Tonix Pharmaceuticals Announces Two Publications of Data in American Journal of Transplantation Showing TNX-1500 (Anti-CD40L mAb) Prolongs Nonhuman Primate Renal and Heart Allograft SurvivalApril 17th, 2023
- Join now to see all